Clinical Trials Logo

Fatty Liver Disease clinical trials

View clinical trials related to Fatty Liver Disease.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04175392 Terminated - Cirrhosis, Liver Clinical Trials

Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis

PRONE
Start date: January 12, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This study will evaluate the effect of probiotics, a beneficial intestinal bacteria supplement, if it will cause improvement of the non-alcoholic fatty liver disease (NAFLD) and or non-alcoholic steatohepatitis (NASH- an inflammation with concurrent fatty accumulation of the liver) as measured by transient elastography - an ultrasound of the liver that assess the elastic properties (density) and stiffness of the liver tissue. This study will enroll patients 18 years and older with diagnosis of NAFLD and or NASH.